title: Electrolyte disturbances and acute kidney injury in patients with cancer.
abstract: The interrelation between kidney disease and cancer is complex and reciprocal. Among the most frequent cancer-associated kidney diseases are the electrolyte and acid-base disturbances, which occur frequently and often are associated with an ominous prognosis, and acute kidney injury. Tumor lysis syndrome is a potentially life-threatening condition that frequently occurs in patients with a high tumor burden and high cellular turnover after cytotoxic therapy (including steroids in steroid-sensitive hematologic malignancies). Electrolyte and acid-base disturbances are the consequence of neoplastic spread, anticancer treatment, or, more rarely, paraneoplastic phenomena of all types of tumors. This article reviews hyponatremia and hypernatremia, hypokalemia and hyperkalemia, hypomagnesemia, hypercalcemia and hypocalcemia, hypophosphatemia, and the most important disturbances in acid-base balance in cancer patients. Acute kidney injury (AKI) is a frequent occurrence in cancer patients and has the potential to substantially alter the outcome of patients with cancer and jeopardize their chances of receiving optimal cancer treatment and a potential cure. As in many other circumstances, the etiology of AKI in cancer patients is multifactorial. Initiation and/or continuation of dialysis in the AKI cancer patient should be based on the general clinical condition and overall life expectancy and the personal patient expectations on quality of life after eventual recovery.
authors.affiliation: Renal Division, University Hospital, Gent, Belgium. norbert.lameire@ugent.be
authors.forename: Norbert
authors.initials: N
authors.lastname: Lameire
authors.forename: Wim
authors.initials: W
authors.lastname: Van Biesen
authors.forename: Raymond
authors.initials: R
authors.lastname: Vanholder
mesh_terms: D000140:Acidosis, Lactic / Q000209:etiology; D000141:Acidosis, Renal Tubular / Q000209:etiology; D058186:Acute Kidney Injury / Q000209:etiology* / Q000628:therapy*; D000471:Alkalosis; D006801:Humans; D053565:Hypercalciuria / Q000209:etiology; D017674:Hypophosphatemia / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D009397:Nephrocalcinosis / Q000209:etiology; D011379:Prognosis; D055677:Refeeding Syndrome; D015499:Renal Tubular Transport, Inborn Errors / Q000209:etiology; D015275:Tumor Lysis Syndrome / Q000150:complications / Q000628:therapy; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy* / Q000209:etiology* / Q000628:therapy